Physician profile
Sameer A Hirji
NPI 1669866760
$17,796.72
in general payments reported to CMS, 2019-2025
15 companies · $9,400 in 2025
The $9,400 reported for 2025 was more than what 89% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2021: $229 · 2022: $640 · 2023: $2,011 · 2024: $5,246 · 2025: $9,400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,465 · Travel and Lodging: $4,742 · Food and Beverage: $3,247 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,833 · Honoraria: $300 · Education: $68.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,465.00 |
| Travel and Lodging | $4,742.33 |
| Food and Beverage | $3,247.24 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,833.00 |
| Honoraria | $300.00 |
| Education | $68.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $5,865.14 | 2019-2025 | Pascal, Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve |
| Medtronic, INC. | $5,286.51 | 2022-2025 | Corevalve Evolut R, Avalus, Penditure |
| Olympus Medical Systems Corporation | $1,710.00 | 2023 | Oes Choledochofiberscope |
| W. L. Gore & Associates, INC. | $1,633.00 | 2025 | Product In Development |
| Artivion, INC. | $1,597.49 | 2024-2025 | Cardiac Non-Synergraft, Bioglue Surgical Adhesive, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Becton, Dickinson and Company | $475.00 | 2025 | |
| Stryker Corporation | $325.37 | 2023-2025 | Na |
| Vascular Technology, INC. | $300.00 | 2025 | |
| Abiomed | $161.39 | 2024-2025 | Impella |
| Baxter Healthcare | $136.45 | 2025 | Coseal |
| Lemaitre Vascular, INC. | $125.00 | 2025 | Restoreflow |
| Bolton Medical INC | $75.50 | 2025 | Treo Abdominal Stent-Graft System |
| Terumo Cardiovascular Systems Corporation | $50.31 | 2022 | |
| Corcym INC | $36.84 | 2025 | Perceval |
| Abbott Laboratories | $18.72 | 2025 | Navitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Hirji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.